Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ranbaxy’s Woes Add $900 Million to U.S. Heart Drug Costs
Ranbaxy’s Woes Add $900 Million to U.S. Heart Drug Costs
Ranbaxy’s Woes Add $900 Million to U.S. Heart Drug Costs
Submitted by
admin
on April 15, 2014 - 10:05am
Source:
Bloomberg
News Tags:
Ranbaxy
generics
Novartis
Diovan
Headline:
Ranbaxy’s Woes Add $900 Million to U.S. Heart Drug Costs
Do Not Allow Advertisers to Use My Personal information
